Satoru Ito

ORCID

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 4

Top Venues

Journal of medicinal chemistry

ACS medicinal chemistry letters

This page only lists publications with an associated author ORCID identifier.

Publications

James E H Day, Valerio Berdini, Joan Castro, Gianni Chessari, Thomas G Davies, Philip J Day, Jeffrey D St Denis, Hideto Fujiwara, Satoshi Fukaya, Christopher C F Hamlett, Keisha Hearn, Steven D Hiscock, Rhian S Holvey, Satoru Ito, Navrohit Kandola, Yasuo Kodama, John W Liebeschuetz, Vanessa Martins, Kenichi Matsuo, Paul N Mortenson, Sandra Muench, Yoko Nakatsuru, Hiroaki Ochiiwa, Nicholas Palmer, Torren Peakman, Amanda Price, Michael Reader, David C Rees, Sharna J Rich, Alpesh Shah, Yoshihiro Shibata, Tomoko Smyth, David G Twigg, Nicola G Wallis, Glyn Williams, Nicola E Wilsher, Andrew Woodhead, Tadashi Shimamura, Christopher N Johnson
Fragment-Based Discovery of Allosteric Inhibitors of SH2 Domain-Containing Protein Tyrosine Phosphatase-2 (SHP2). Journal of medicinal chemistry 67 (6) (2024)
James E H Day, Valerio Berdini, Joan Castro, Gianni Chessari, Thomas G Davies, Philip J Day, Jeffrey D St Denis, Hideto Fujiwara, Satoshi Fukaya, Christopher C F Hamlett, Keisha Hearn, Steven D Hiscock, Rhian S Holvey, Satoru Ito, Navrohit Kandola, Yasuo Kodama, John W Liebeschuetz, Vanessa Martins, Kenichi Matsuo, Paul N Mortenson, Sandra Muench, Yoko Nakatsuru, Hiroaki Ochiiwa, Nicholas Palmer, Torren Peakman, Amanda Price, Michael Reader, David C Rees, Sharna J Rich, Alpesh Shah, Yoshihiro Shibata, Tomoko Smyth, David G Twigg, Nicola G Wallis, Glyn Williams, Nicola E Wilsher, Andrew Woodhead, Tadashi Shimamura, Christopher N Johnson
Fragment-Based Discovery of Allosteric Inhibitors of SH2 Domain-Containing Protein Tyrosine Phosphatase-2 (SHP2). Journal of medicinal chemistry (2024)
James E H Day, Valerio Berdini, Joan Castro, Gianni Chessari, Thomas G Davies, Philip J Day, Jeffrey D St Denis, Hideto Fujiwara, Satoshi Fukaya, Christopher C F Hamlett, Keisha Hearn, Steven D Hiscock, Rhian S Holvey, Satoru Ito, Navrohit Kandola, Yasuo Kodama, John W Liebeschuetz, Vanessa Martins, Kenichi Matsuo, Paul N Mortenson, Sandra Muench, Yoko Nakatsuru, Hiroaki Ochiiwa, Nicholas Palmer, Torren Peakman, Amanda Price, Michael Reader, David C Rees, Sharna J Rich, Alpesh Shah, Yoshihiro Shibata, Tomoko Smyth, David G Twigg, Nicola G Wallis, Glyn Williams, Nicola E Wilsher, Andrew Woodhead, Tadashi Shimamura, Christopher N Johnson
Fragment-Based Discovery of Allosteric Inhibitors of SH2 Domain-Containing Protein Tyrosine Phosphatase-2 (SHP2). Journal of medicinal chemistry 67 (6) (2024)
Satoru Ito, Sachie Otsuki, Hirokazu Ohsawa, Atsushi Hirano, Hideki Kazuno, Satoshi Yamashita, Kosuke Egami, Yoshihiro Shibata, Ikuo Yamamiya, Fumiaki Yamashita, Yasuo Kodama, Kaoru Funabashi, Hiromi Kazuno, Toshiharu Komori, Satoshi Suzuki, Hiroshi Sootome, Hiroshi Hirai, Takeshi Sagara
Discovery of Futibatinib: The First Covalent FGFR Kinase Inhibitor in Clinical Use. ACS medicinal chemistry letters 14 (4) (2023)

Satoru Ito.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Satoru Ito